Overview
Xiaodan Huang practices practicing medicine in Beijing, China.
Their clinical expertise encompasses Lung Metastases, Cervical Cancer, Lung Cancer, and Nasopharyngeal Carcinoma.
They are actively involved in clinical research, co-authoring 31 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xiaodan Huang
Is Xiaodan Huang a top-rated expert for Lung Metastases?
MediFind is an objective health platform that identifies experts based on real-world data. Xiaodan Huang is classified as an Experienced expert for Lung Metastases, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xiaodan Huang participate in research or clinical trials?
Yes. Xiaodan Huang has published 31 articles and abstracts on conditions like Lung Metastases. You can view a list of Xiaodan Huang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cervical CancerHuang isExperienced. Learn about Cervical Cancer.
- Lung CancerHuang isExperienced. Learn about Lung Cancer.
- Lung MetastasesHuang isExperienced. Learn about Lung Metastases.
- Nasopharyngeal CarcinomaHuang isExperienced. Learn about Nasopharyngeal Carcinoma.
- Non-Small Cell Lung Cancer (NSCLC)